Klausen, P <br/><br/>
Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.  [electronic resource] 

 -  Oncogene  Jul 2000 
 - 3675-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1203707  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CDC2-CDC28 Kinases<br/>Cell Cycle--drug effects<br/>Cell Cycle Proteins<br/>Cyclin-Dependent Kinase 2<br/>Cyclin-Dependent Kinase Inhibitor p27<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>Cytokines--metabolism<br/>DNA--biosynthesis<br/>DNA-Binding Proteins--metabolism<br/>Growth Inhibitors--metabolism<br/>Humans<br/>Interleukin-10--genetics<br/>Interleukin-6--metabolism<br/>Leukemia Inhibitory Factor<br/>Lymphokines--metabolism<br/>Microtubule-Associated Proteins--metabolism<br/>Milk Proteins<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Oncostatin M<br/>Peptides--metabolism<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Rats<br/>Receptors, Interleukin--genetics<br/>Receptors, Interleukin-10<br/>STAT3 Transcription Factor<br/>STAT5 Transcription Factor<br/>Trans-Activators--metabolism<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Proteins<br/>Up-Regulation